For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
SANTA CRUZ, CALIFORNIA, USA, March 4, 2024 / EINPresswire.com / -- RealSeq offers comprehensive next-generation sequencing (NGS) workflows to advance transcriptomics, large-scale RNA sequencing and to ...
Zacks Investment Research on MSN
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals
In the first nine months of 2025, Tempus AI Inc. TEM achieved several key regulatory milestones that strengthened its position in AI-driven diagnostics. In September 2025, the company received FDA 510 ...
Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind of pathogen. A genomic test developed at UC San Francisco to rapidly detect ...
CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully RNA-encoded, site-specific gene-integration system, presented at the Cold ...
The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...
SANTA CRUZ, CALIFORNIA, USA, March 4, 2024 / EINPresswire.com / -- RealSeq offers comprehensive next-generation sequencing (NGS) workflows to advance transcriptomics, large-scale RNA sequencing and to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback